The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThalassa (di) Regulatory News (THAL)

Share Price Information for Thalassa (di) (THAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.50
Bid: 23.00
Ask: 26.00
Change: 0.00 (0.00%)
Spread: 3.00 (13.043%)
Open: 24.50
High: 24.50
Low: 24.50
Prev. Close: 24.50
THAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Share Buy-Back Programme

6 Mar 2019 07:01

RNS Number : 9523R
Thalassa Holdings Limited
06 March 2019
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014.

FOR IMMEDIATE RELEASE

6 March 2019

 

Thalassa Holdings Ltd

(Reuters: THAL.L, Bloomberg: THAL:LN)

("Thalassa", "THAL" or the "Company")

New Share Buy-Back Programme

 

Further to the Company's announcement of 17 October 2018 announcing an increase to Thalassa's share buy-back programme, the Board has resolved on 5 March 2019 to approve a new share buy-back authority of up to £6.0 million of Thalassa ordinary shares, which replaces the unutilised headroom in the current authority.

 

This new programme will remain in place irrespective of the Company's proposed offer for The Local Shopping REIT Plc. WH Ireland Limited ("WHI"), the Company's broker, is authorised to purchase ordinary shares in the Company whilst the Offer Period continues, subject to an agreed maximum price per share, but otherwise entirely at its discretion. Such purchases will be made by WHI on the Company's behalf in accordance with the Company's Articles of Association and pursuant to the new Board authority dated 5 March 2019 to buy-back up to £6,000,000 of the Company's shares.

 

The Company has to date purchased 4,803,590 shares under its previous authority for a total cost of £4,227,807.31 or an average price of 88.01 pence per share. The average purchase price of the total number of shares held in treasury, 7,912,247 shares, is 70.45 pence per share for a cost of £5,574,246.41. Any purchases will be reported as they take place. Whilst the Company's share price is below net asset value per share, the Board's opinion is that buying-back shares is a means by which shareholder value can be enhanced.

 

Investor Enquiries: 

 

Thalassa Holdings Ltd 

 

Duncan Soukup, Chairman +33 (0)6 78 63 26 89

 

WH Ireland Limited (Financial Advisor) 

 

Chris Fielding, Managing Director, Corporate Finance +44 (0)207 220 1650 

 

www.thalassaholdingsltd.com  

 

Note to Editors:

Thalassa Holdings Ltd, incorporated and registered in the BVI, is a holding company with various interests across a number of industries.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFELLBKXFFBBL
Date   Source Headline
12th Jan 20247:36 amEQSThalassa Holdings Ltd: Trading Update
16th Nov 202312:27 pmEQSThalassa Holdings Ltd: TR1
29th Sep 20239:01 amEQSThalassa Holdings Ltd: Interim Results (30 June 2023)
28th Sep 202311:09 pmEQSThalassa Holdings Ltd: Amendment to Articles of Association
17th Jul 20238:12 amEQSThalassa Holdings Ltd: Restoration of Listing
10th Jul 202310:50 amEQSThalassa Holdings Ltd: Final Results For Year Ended 31 December 2022
30th Jun 20237:57 pmEQSThalassa Holdings Ltd: Result of AGM
7th Jun 20237:51 pmEQSThalassa Holdings Ltd: AGM Proxy Form
5th Jun 202311:20 amEQSThalassa Holdings Ltd: Notice of AGM
2nd May 20237:51 amEQSThalassa Holdings Ltd: Temporary Suspension
2nd May 20237:30 amRNSSuspension - Thalassa Holdings Ltd
19th Apr 20238:45 pmEQSAppointment of Auditor
14th Feb 20234:12 pmEQSThalassa Holdings Ltd: Confirmation of previously announced proposal
27th Jan 20233:40 pmEQSThalassa Holdings Ltd: Trading Statement
27th Jan 20232:40 pmEQSThalassa Holdings Ltd: Trading Statement
13th Dec 20227:38 pmEQSThalassa Holdings Ltd: STR-Statement re resignation of auditor
13th Dec 20226:38 pmEQSThalassa Holdings Ltd: STR-Statement re resignation of auditor
24th Oct 20228:35 amEQSThalassa Holdings Ltd: Correction
24th Oct 20228:34 amEQSThalassa Holdings Ltd: Correction
21st Oct 202211:00 amEQSThalassa Holdings Ltd: Directorate Change
21st Oct 202210:59 amEQSThalassa Holdings Ltd: Directorate Change
15th Aug 20227:01 amEQSThalassa Holdings Ltd: Interim Results
15th Aug 20227:00 amEQSThalassa Holdings Ltd: Interim Results
28th Jun 20223:47 pmEQSThalassa Holdings Ltd: Result of AGM
28th Jun 20223:47 pmEQSThalassa Holdings Ltd: Result of AGM
27th Jun 20221:03 pmEQSThalassa Holdings Ltd: Appointment of Broker
27th Jun 20221:02 pmEQSThalassa Holdings Ltd: Appointment of Broker
9th Jun 20223:37 pmEQSThalassa Holdings Ltd: Final Results for Year Ended 31 December 2021
9th Jun 20223:34 pmEQSThalassa Holdings Ltd: Final Results for Year Ended 31 December 2021
9th Jun 20223:19 pmEQSThalassa Holdings Ltd: Notice of AGM
9th Jun 20223:18 pmEQSThalassa Holdings Ltd: Notice of AGM
24th May 202211:27 amEQSThalassa Holdings Ltd: Appointment of Non-Executive Director
28th Feb 20221:37 pmEQSThalassa Holdings Ltd: Trading Statement
17th Dec 20217:17 amRNSReverse Takeover of id4 AG by Anemoi International
15th Nov 20219:01 amRNSid4 delivers Client Space solution
28th Oct 20215:00 pmRNSHolding(s) in Company
7th Oct 20213:59 pmRNSResult of AGM
28th Sep 20217:00 amRNSInterim Results
17th Sep 202112:50 pmRNSLondon Medical Laboratory investment update
30th Jul 20213:23 pmRNSProposed Transaction
22nd Jun 202110:29 amRNSFinal Results for YE 31 Dec 2020 and Notice of AGM
14th Jun 20217:00 amRNSPreliminary Results for the year ended 31 Dec 20
29th Apr 20217:01 amRNSGrant Funded Project for Autonomous Robotics Ltd
29th Apr 20217:00 amRNSNotice of Results
8th Mar 20217:00 amRNSDe-listing from Luxembourg Stock Exchange
3rd Mar 20217:00 amRNSAppointment of Chief Financial Officer
4th Feb 202111:17 amRNSThalassa subsidiary id4 wins at Swiss WB Awards
2nd Feb 20217:00 amRNSInvestment in London Medical Laboratory Limited
23rd Dec 20207:00 amRNSAppointment of Director to Tappit Technologies
3rd Dec 20202:49 pmRNSShare Buy-Back

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.